Publication | Closed Access

Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial

Fact TrialGastrointestinal OncologyMedicineSurgeryCancer TreatmentOncologyRadiation OncologyCancer ChemotherapyCancer ResearchNeoadjuvant Chemotherapy